Priscilla Young
Psychiatric/Mental Health · Augusta, MENPI 1881789766
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 42.9% of the total.
Across 38 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$352
- Teva Pharmaceuticals USA, Inc.$105
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$73
- Johnson & Johnson$54
- Vanda Pharmaceuticals Inc.$54
- Indivior Inc.$51
- plus $132 from 4 others
What the payments were for
- Food & beverage$77394%
- Education$476%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $352 |
| Teva Pharmaceuticals USA, Inc. | 4 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $73 |
| Johnson & Johnson | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Indivior Inc. | 2 | $51 |
| Sunovion Pharmaceuticals Inc. | 6 | $51 |
| Gilead | 2 | $39 |
| Lundbeck LLC | 1 | $27 |
| Braeburn Inc. | 1 | $15 |
How this compares
$820 in reported general payments places this provider in the 80th percentile of 192 psychiatric/mental health providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 17 | $8,492 |
| VyvanseLisdexamfetamine Dimesylate | 20 | $8,245 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 55 | $6,321 |
| Chlorpromazine Hcl | 13 | $4,996 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 13 | $3,661 |
| Methylphenidate Hcl | 57 | $1,950 |
| Methylphenidate ErMethylphenidate Hcl | 20 | $1,262 |
| Quetiapine Fumarate | 28 | $1,137 |
| Aripiprazole | 34 | $1,132 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $1,035 |
| Duloxetine Hcl | 30 | $698 |
| Olanzapine | 23 | $633 |
| Bupropion XlBupropion Hcl | 19 | $588 |
| Prazosin Hcl | 18 | $585 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 29 | $553 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Augusta
- Larry SextonAugusta$15K
- Marianne TarrazaScarborough$22K
- Kelly BraggMadison$21K
- Michelle ChmeleckiPortland$12K
- Bethney SeifertBangor$8K
- Janet ZalanskasWaterville$6K
- Susan MartinScarborough$6K
- Samuel KingsleyScarborough$6K
- Alison CameronScarborough$5K
- Marta HallWaterville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.